Quick Heal grants 2.2 lakh stock options to employees
Quick Heal Technologies granted 2,20,000 stock options to employees under its ESOP Scheme 2021, approved by the Nomination and Remuneration Committee on June 18, 2026. The options are exercisable into equity shares with a face value of ₹10, featuring a split pricing structure of ₹10 and ₹87 per option. Vesting occurs between one and four years, with a three-year window to exercise vested options.

*this image is generated using AI for illustrative purposes only.
Quick Heal Technologies has granted 2,20,000 stock options to employees under its ESOP Scheme 2021. The grant was approved by the company's Nomination and Remuneration Committee on June 18, 2026. This move aims to incentivize employees through equity participation, aligning their interests with the growth of the company.
The options are exercisable into 2,20,000 equity shares, each with a face value of ₹10. The pricing structure for the grant is divided into two categories. A total of 2,00,000 options have an exercise price of ₹10 each, while the remaining 20,000 options are priced at ₹87 each. The price of ₹87 represents a 50% discount based on the NSE closing share price on June 17, 2026.
Vesting and Exercise Details
The stock options come with specific vesting and exercise timelines designed to retain talent over the medium term. The options will vest after a minimum period of one year but no later than four years from the date of grant. Once vested, the options can be exercised by the holders to acquire an equivalent number of equity shares upon payment of the exercise price and applicable taxes.
All vested options must be exercised within a maximum period of three years from the date of vesting. This structure provides employees with a defined window to realize the benefits of their options, subject to the terms and conditions of the ESOP Scheme 2021.
Regulatory Compliance
The grant of options has been executed in compliance with the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The disclosure was submitted to the stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The following table summarizes the key details of the grant:
| Particulars | Details |
|---|---|
| Total Options Granted | 2,20,000 |
| Shares Covered | 2,20,000 equity shares of ₹10 each |
| Exercise Price (2,00,000 Options) | ₹10 per option |
| Exercise Price (20,000 Options) | ₹87 per option |
| Minimum Vesting Period | 1 year |
| Maximum Vesting Period | 4 years |
| Exercise Window | Within 3 years of vesting |
No options have been exercised, lapsed, or varied in terms at this stage. The company stated that diluted earnings per share calculations are not applicable at this current stage of the grant process.
Historical Stock Returns for Quick Heal Technologies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.97% | +7.15% | -11.72% | -32.90% | -49.72% | -26.37% |
How will the issuance of these new options impact Quick Heal's existing shareholding structure and potential dilution?
What is the company's strategy for funding future ESOP grants as it continues to expand its talent pool?
How might this ESOP scheme influence employee retention rates and overall productivity in the coming years?

































